Angiotensin-converting enzyme 2 (ACE2) is the first human homologue of ACE to be
described. ACE2 is a type I integral membrane protein that functions as a carboxypeptidase …

Components of the renin–angiotensin system are well established targets for
pharmacological intervention in a variety of disorders. Many such therapies abrogate the …

Angiotensin-converting enzyme (ACE) is a zinc metalloproteinase and a key regulator of the
renin–angiotensin system (RAS). ACE2 is a newly described enzyme identified in rodents …

The renin-angiotensin system (RAS) has been recognized for many years as critical
pathway for blood pressure control and kidney functions. Although most of the well-known …

The renin–angiotensin system (RAS) has pivotal roles in the regulation of normal physiology
and the pathogenesis of cardiovascular disease. Angiotensin-converting enzyme (ACE) 2 …

The discovery of angiotensin-converting enzyme 2 (ACE-2) has revealed a far more
complex enzymatic cascade that may influence the renin-angiotensin system within the …

The renin‐angiotensin system (RAS) is a critical regulator of hypertension, primarily through
the actions of the vasoactive peptide Ang II, which is generated by the action of angiotensin …

Angiotensin-converting enzyme 2: implications for blood pres... : Current Opinion in Nephrology
and Hypertension Angiotensin-converting enzyme 2: implications for blood pressure and kidney …

The discovery of angiotensin-converting enzyme 2 (ACE2) in 2000 is an important event in
the renin-angiotensin system (RAS) story. This enzyme, an homolog of ACE, hydrolyzes …

The renin–angiotensin system (RAS) is critically involved in cardiovascular and renal
function and in disease conditions, and has been shown to be a far more complex system …